COMBINAGE Trademark
Trademark Overview
On Tuesday, July 25, 2023, a trademark application was filed for COMBINAGE with the United States Patent and Trademark Office. The USPTO has given the COMBINAGE trademark a serial number of 79377556. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 17, 2024. This trademark is owned by Rejuvenate Biomed NV. The COMBINAGE trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable artificial intelligence software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; downloadable artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; downloadable artificial intelligence software for data analysis; downloadable software using artificial intelligence for machine learning for healthcare; downloadable health monitoring software for data analysis; downloadable software relating to the medical field for controlling and managing patient medical information; downloadable software for data analysis relating to the pharmaceutical field for drug discovery and development; downloadable bioinformatics software for drug discovery and development, for controlling and managing patient medical information; electronic databases, namely, downloadable databases and electronic database recorded on...
Pharmaceutical services, namely, pharmaceutical compounding, pharmaceutical advice; pharmaceutical consultation; pharmaceutical advisory services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services; medical consultancy services; medical advisory services; medical evaluation services, namely, medical testing for fitness evaluation, medical evaluation of cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and conditions, conducting medical physical evaluations; medical diagnostic services; medical examination services; services for the provision of medical care information, namely, providing medical care information, providing medical care information ...
Providing temporary use of non-downloadable artificial intelligence computer programs on data networks for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; platforms for artificial intelligence as software as a service (SaaS), namely, platform as a service (PAAS) featuring computer software platforms using artificial intelligence for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring computer software platforms for data analysis for artificial intelligence for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and devel...
General Information
| Serial Number | 79377556 |
| Word Mark | COMBINAGE |
| Filing Date | Tuesday, July 25, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 17, 2024 |
Trademark Statements
| Goods and Services | Downloadable artificial intelligence software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; downloadable artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; downloadable artificial intelligence software for data analysis; downloadable software using artificial intelligence for machine learning for healthcare; downloadable health monitoring software for data analysis; downloadable software relating to the medical field for controlling and managing patient medical information; downloadable software for data analysis relating to the pharmaceutical field for drug discovery and development; downloadable bioinformatics software for drug discovery and development, for controlling and managing patient medical information; electronic databases, namely, downloadable databases and electronic database recorded on computer media, for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data |
| Pseudo Mark | COMBINE AGE |
| Goods and Services | Pharmaceutical services, namely, pharmaceutical compounding, pharmaceutical advice; pharmaceutical consultation; pharmaceutical advisory services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services; medical consultancy services; medical advisory services; medical evaluation services, namely, medical testing for fitness evaluation, medical evaluation of cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and conditions, conducting medical physical evaluations; medical diagnostic services; medical examination services; services for the provision of medical care information, namely, providing medical care information, providing medical care information via a website; medical services for the diagnosis of conditions of the human body; medical services for the treatment of conditions of the human body; medical care and analysis services relating to patient treatment; medical screening; drug screening for medical purposes; genetic testing for medical purposes |
| Goods and Services | Providing temporary use of non-downloadable artificial intelligence computer programs on data networks for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; platforms for artificial intelligence as software as a service (SaaS), namely, platform as a service (PAAS) featuring computer software platforms using artificial intelligence for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring computer software platforms for data analysis for artificial intelligence for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SaaS) services featuring artificial intelligence software for data analysis; software as a service (SaaS) services featuring software using artificial intelligence for machine learning for healthcare; software as a service (SaaS) services featuring health monitoring software for monitoring health data; software as a service (SaaS) services featuring software relating to the medical field for controlling and managing patient medical information; software as a service (SaaS) services featuring bioinformatics software for drug discovery and development, for controlling and managing patient medical information; providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; computer programming in the medical field; scientific computer programming services; artificial intelligence technology consultancy; research in the field of artificial intelligence; pharmaceutical research services; pharmaceutical products development; pharmaceutical product evaluation; research of pharmaceuticals; testing of pharmaceuticals; research relating to pharmaceuticals; development of gene-based medicines; conducting clinical trials for others for pharmaceutical products; laboratory research services relating to pharmaceuticals; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals, pharmaceutical research and development; information technology services for the pharmaceutical and healthcare industries, namely information technology consultancy relating to installation, maintenance and repair of computer software; conducting early evaluations in the field of new pharmaceuticals, namely, testing of pharmaceuticals; providing information about pharmaceutical research, namely, the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical research and analysis services; medical and pharmacological research services; scientific research for medical purposes; drug discovery services; medical and scientific research, namely, conducting clinical trials for others; genetic research, namely, providing scientific research information in the field of genetics, providing medical research information in the field of genetics; genetic mapping for scientific purposes; providing scientific information in the field of medical disorders and their treatment |
Classification Information
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 7, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 7, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 7, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Rejuvenate Biomed NV |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 98 - Unknown |
| Address | BE |
| Party Name | Rejuvenate Biomed NV |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Party Name | Rejuvenate Biomed NV |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | BE |
Trademark Events
| Event Date | Event Description |
| Thursday, August 31, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, September 7, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 12, 2023 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 27, 2024 | ASSIGNED TO EXAMINER |
| Thursday, March 28, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, March 29, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, April 17, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, April 17, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, May 8, 2024 | REFUSAL PROCESSED BY IB |
| Friday, May 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, June 29, 2024 | FINAL REFUSAL WRITTEN |
| Saturday, June 29, 2024 | FINAL REFUSAL E-MAILED |
| Saturday, June 29, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, August 13, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 13, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 13, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 13, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 13, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 28, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, November 8, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
